RE:Uplist is next logical stepIt would be nice but not necessary.
At some point , Symrise will acquire Ceapro lock stock and barrel and make it their NA production and distribution center .
What is unique about Ceapro is that it is one of very few health and wellness companies listed on public exchanges.
Given its advanced plans to expand iinto the profitable nutraceutical and pharmaceutical sectors., launching its first two Clnical trials this year, and it's disruptive PGX technology which provides a fourth revenue stream, Ceapro offers current, near term and extended term drivers of growth and profitability.
Just buy and hold Ceapro for 5 years and a $25 target is not at all unreasonable ..